Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Zachary A. Kohutek

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-3220-6673; OpenAlex author ID A5034640824. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 3 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer. First author DOI 10.1158/2159-8290.cd-24-0772↗
  2. The Evolutionary Forest of Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-23-1541↗
  3. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s43018-019-0010-1↗
  4. The Genetic Basis of Transcriptional and Spatial Heterogeneity of Squamous Features in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/548354↗
  5. Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Co-author DOI 10.1038/ng.3764↗
  6. An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course. Co-author DOI 10.1101/mcs.a001701↗
  7. Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-15-1615↗
  8. Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/nm.3919↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christine A. Iacobuzio–Donahue · 8 shared papers, 2015–2026 · strength 0.85
  2. Jungeui Hong · 5 shared papers, 2017–2026 · strength 0.67
  3. Laura DeLong Wood · 5 shared papers, 2017–2026 · strength 0.67
  4. Alvin P. Makohon-Moore · 7 shared papers, 2015–2025 · strength 0.57
  5. Haochen Zhang · 2 shared papers, 2025–2026 · strength 0.48
  6. Marc A. Attiyeh · 5 shared papers, 2017–2025 · strength 0.47
  7. Eileen Mary O'Reilly · 2 shared papers, 2020–2026 · strength 0.36
  8. Hitomi Sakamoto · 3 shared papers, 2019–2025 · strength 0.34
  9. Akimasa Hayashi · 3 shared papers, 2019–2025 · strength 0.34
  10. Marsha Reyngold · 1 shared paper, 2026 · strength 0.28
  11. Christopher H. Crane · 1 shared paper, 2026 · strength 0.28
  12. Ralph H. Hruban MD · 4 shared papers, 2015–2020 · strength 0.24
  13. Yi Zhong · 3 shared papers, 2017–2020 · strength 0.21
  14. Katelyn Mullen · 1 shared paper, 2025 · strength 0.20
  15. Marinela Capanu · 1 shared paper, 2025 · strength 0.20
  16. Caitlin A. McIntyre · 1 shared paper, 2025 · strength 0.20
  17. Benjamin J. Raphael · 1 shared paper, 2025 · strength 0.20
  18. Olca Baştürk · 2 shared papers, 2019–2020 · strength 0.15
  19. Lauren M. Rosati · 1 shared paper, 2017 · strength 0.07
  20. Joseph M. Herman · 1 shared paper, 2017 · strength 0.07
  21. Martin C. Whittle · 1 shared paper, 2017 · strength 0.06
  22. Brian T. Herbst · 1 shared paper, 2017 · strength 0.06
  23. Steven D Leach · 1 shared paper, 2017 · strength 0.06
  24. Sunil R. Hingorani · 1 shared paper, 2017 · strength 0.06
  25. Bert Vogelstein · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.